Savitz Ryan: insider trades.
Savitz Ryan reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.2M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Savitz Ryan
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Officer · EVP, CFO & CBO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-09 | Dianthus Therapeutics, Inc. /DE/ | M | 31,249 | $21.77 | 31,249 | Form 4 |
| 2026-07-09 | Dianthus Therapeutics, Inc. /DE/ | S | 10,354 | $100.22 | 20,895 | Form 4 |
| 2026-07-09 | Dianthus Therapeutics, Inc. /DE/ | S | 5,566 | $101.97 | 0 | Form 4 |
| 2026-07-09 | Dianthus Therapeutics, Inc. /DE/ | S | 15,329 | $101.24 | 5,566 | Form 4 |
Questions
What stock did Savitz Ryan buy or sell?
Savitz Ryan reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.2M), across 1 company.
Is Savitz Ryan the same person as other filers with this name?
This page covers SEC CIK 1992324 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/savitz-ryan-1992324.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.